You are here: Home:  CCU 1 | 2004: Faculty Disclosures


FACULTY DISCLOSURES

As a provider accredited by the ACCME, it is the policy of Research To Practice to require the disclosure of any significant financial interest or any other relationship the sponsor or faculty members have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following:


Lee M Ellis, MD

Grants/Research Support: ImClone Systems, AstraZeneca Pharmaceuticals LP
Consultant: ImClone Systems, Attenuon LLC
Honorarium: Genentech BioOncology

David Cunningham, MD, FRCP Consultant and Honorarium: Sanofi Synthelabo Inc, Aventis Pharmaceuticals Inc, AstraZeneca Pharmaceuticals LP, Merck and Company Inc, Roche Laboratories Inc
Mark S Roh, MD No financial interests or affiliations to disclose

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor.

 

Table of Contents Top of Page

Home

Editor’s Note:
A call to action
 
Lee M Ellis, MD
- Select publications
 
David Cunningham, MD, FRCP
- Select publications
 
Mark S Roh, MD
- Select publications
 

Faculty Disclosures

A CME Audio Series and Activity

Editor's office

 

Terms of use and general disclaimer
© Research To Practice, 2004. All rights reserved.